“Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 cm2 of the Face and Scalp in Patients with Actinic Keratosis: A Phase 3 Study” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s264. doi:10.25251/skin.7.supp.264.